IAPP and Parkinson disease: Furthermore, given that amphipathic helix-mediated aggregation was previously observed in α-Synuclein, islet amyloid polypeptide, and apolipoprotein C-II90–93, this approach may not be limited to HD but could also be used for other diseases such as Parkinson’s disease, diabetes, and cardiac amyloidosis.